Moody's Investors Service affirmed its "A2" rating for the Baltimore-based University of Maryland Medical System, affecting $1.1 billion of outstanding debt.
The rating favorably acknowledges that the system's strong brand and leadership position, combined with its substantial geographic reach, will continue to lead to a notable market share and high patient demand. However, the rating will remain constrained by a modest balance sheet, a competitive operating environment and significant capital spending plans.
The rating outlook remains negative.